OraLiva
OraLiva, Inc.
OraLiva, Inc. is an innovative medical technology company specializing in the development of advanced early detection diagnostics for oral cancer. By leveraging cutting-edge technology, the company aims to address the critical issue of late-stage cancer diagnosis, enhancing patient outcomes through timely intervention.
Products & Team
ONC-InCyt Technology
The ONC-InCyt technology is a portable, programmable cytology platform designed for point-of-care use. This advanced diagnostic tool utilizes a microfluidic engine to process cells and deliver reliable diagnostics for oral cancer and oral dysplasia.
The ONC-InCyt technology addresses the pervasive issue of late-stage cancer diagnosis, enabling healthcare providers to identify oral cancers and dysplasia at the earliest possible stage, thus improving patient outcomes through prompt treatment.
Patients and providers face challenges with late-stage cancer diagnoses, which result in poor prognoses. OraLiva addresses this pain point by providing a tool that ensures early detection and potentially life-saving interventions.